Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | €3.82 | €33.73 | 782.942% |
BeiGene Ltd ADR | 9 | 1 | 1 | 0 | €141.00 | €241.54 | 71.307% |
Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 0 | €4.76 | €13.60 | 185.662% |
MannKind Corp. | 8 | 0 | 1 | 0 | €4.41 | €6.03 | 36.647% |
Universal Health Services B | 10 | 3 | 1 | 0 | €165.00 | €161.53 | -2.103% |
Gerresheimer AG | 6 | 0 | 0 | 0 | €105.00 | €110.00 | 4.762% |
Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.86 | €4.00 | 39.860% |
Steris Corp. | 1 | 0 | 0 | 0 | €210.00 | - | - |
Icon plc | 18 | 0 | 0 | 0 | €295.80 | €319.67 | 8.069% |
Sartorius AG VZO | 4 | 0 | 0 | 0 | €253.50 | - | - |
Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €36.61 | €70.00 | 91.231% |
Laboratory Corp. Of America (labcorp) | 11 | 0 | 0 | 0 | €197.00 | €237.94 | 20.782% |
Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.82 | €5.00 | 3.734% |
Vericel Corp. | 1 | 0 | 0 | 0 | €44.40 | - | - |
Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €44.80 | - | - |
Vivoryon Therapeutics N.V. | 1 | 1 | 0 | 1 | €3.20 | - | - |
Virbac S.A. | 1 | 0 | 0 | 0 | €356.00 | - | - |
MorphoSys AG | 7 | 0 | 0 | 0 | €68.00 | €65.00 | -4.412% |
Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.60 | - | - |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.38 | €4.62 | 5.435% |
Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €120.00 | €150.00 | 25.000% |
Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €49.15 | €57.50 | 16.989% |
Brainstorm Cell | 1 | 0 | 0 | 0 | €0.49 | - | - |